Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 5,899 |
|
|||||
| News | - | ||||||
| Day High | 16.1782 | Low High |
|||||
| Day Low | 15.295 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kyverna Therapeutics Inc | KYTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.51 | -3.21% | 15.36 | 09:53:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.96 | 15.295 | 16.1782 | 15.87 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 261 | 5,899 | $ 15.68 | $ 92,475 | - | 12.26 - 35.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:53:43 | 1 | $ 15.3253 | USD |
Kyverna Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 647.85M | 40.82M | - | 0 | -60.37M | -1.48 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kyverna Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KYTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.60 | 17.55 | 12.57 | 15.05 | 362,053 | 2.76 | 21.90% |
| 1 Month | 20.02 | 20.395 | 12.26 | 15.92 | 456,090 | -4.66 | -23.28% |
| 3 Months | 27.19 | 30.60 | 12.26 | 21.71 | 393,988 | -11.83 | -43.51% |
| 6 Months | 34.25 | 35.01 | 12.26 | 23.37 | 433,177 | -18.89 | -55.15% |
| 1 Year | 34.25 | 35.01 | 12.26 | 23.37 | 433,177 | -18.89 | -55.15% |
| 3 Years | 34.25 | 35.01 | 12.26 | 23.37 | 433,177 | -18.89 | -55.15% |
| 5 Years | 34.25 | 35.01 | 12.26 | 23.37 | 433,177 | -18.89 | -55.15% |
Kyverna Therapeutics Description
| Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna¿s pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. |
